Aberrant p16INK4 expression related to clinical stage and prognosis in patients with pancreatic cancer

International Journal of Oncology

Volumn 12, Issue 5, 1998, Pages 1111-1116

  Naka, Takuji ^a   Kobayashi, Makoto ^a   Ashida, Keigo ^a   Toyota, Nobuhiko ^a   Kaneko, Tetsuya ^a   Kaibara, Nobuaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

p16INK4; p53; Pancreatic cancer

Indexed keywords

PROTEIN P16INK4A; PROTEIN P53; DNA; PROTEIN P16; SILVER NITRATE;

AGED; ARTICLE; BIOSYNTHESIS; CANCER INVASION; CANCER STAGING; CELL CYCLE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; PLOIDY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; VASCULARIZATION; ADULT; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SILVER STAINING; TUMOR SUPPRESSOR GENE;

AGED; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PLOIDIES; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031594279     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.5.1111     Document Type: Article

References (28)

1. Griffin CA, Hruban RH, Morsberger LA, Ellingham T, Long PP, Jaffee EM, Hauda KM, Bohlander SK and Yco CJ: Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res 55: 2394-2399, 1995.
2. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boittnot JK, Seidler AJ and Coleman J: Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 161: 120-125, 1991.
3. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J and Pitt HA: Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 consecutive cases. Ann Surg (In press).
4. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
5. Berrozpe G, Schaeffer J, Peinado MA, Real FX and Perucho M: Comparative analysis of mutation in the p53 and K-ras genes in pancreatic cancer, Int J Cancer 58: 185-191, 1994.
6. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ and Kern SE: Frequent somatic mutations and homozygous deletions of the p16(MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8: 27-32, 1994.
7. Liu Q, Yan Y-X, McClure M, Nakagawa H, Fujimura F and Rustgi AK: MTS-1(CDKN2) tumor suppressor gene deletions are frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines. Oncogene 10: 619-622, 1995.
8. Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993.
9. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE III and Skolnick MH: A cell cycle regulator protentially involved in genesis of many tumor types. Science 264: 436-440, 1994.
10. Serrano M, Gomez-Lahoz E, Depinho RA, Beach D and BarSagi D: Inhibition of ras-induced proliferation and cellular transformation by p16. Science 267: 249-252, 1995.
11. Huang L, Goodrow TL, Zhang S-Y, Klein-Szanto AJP, Chang H and Ruggcri BA: Deletion and mutation analyses of the p16/ MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenacarcinomas. Cancer Res 56: 1137-1141, 1996.
12. Japan Pancreas Society: General rules for the pancreatic cancer. 4th edition. Kanehara Press, Tokyo, 1993.
13. Crocker J and Nar P: Nucleolar organizer regions in lymphomas. J Pathol 151: 111-118, 1987.
14. Hedley DW, Friedlander ML, Taylor IW, Rugg CA and Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333-1335, 1983.
15. Hayashi N, Sugimoto Y, Tsuchiya E, Ogawa M and Nakamura Y: Somatic mutation of the MTS (multiple tumor suppressor)1/ CDK4I (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem Biophys Res Commun 202: 1426-1430, 1994.
16. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA and Dracopoli NC: Germline p16 mutations in familial melanoma. Nat Genet 8: 15-21, 1994.
17. Mori T, Miura K, Aoki T, Nishihira T, Mori S and Nanamura Y: Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396-3397, 1994.
18. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J and Sidransky D: High frequency of p16(CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56: 3630-3633, 1996.
19. Geradts J, Kratzke RA, Niehans GA and Lincoln CE: Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/ multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16 in archival human solid tumor: correlation with retinoblastoma protein expression. Cancer Res 55: 6006-6011, 1995.
20. Yokoyama M, Yamanaka Y, Friess H, Buchler M and Korc M: p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness. Anticancer Res 14: 2477-2484, 1994.
21. Zhang SY, Ruggeri B, Agarwal P, Sorling AF, Obara T, Ura H, Namiki M and Szanto K: Immunohistochemical analysis of p53 expression in human pancreatic carcinoma. Arch Pathol Lab Med 118: 150-154, 1994.
22. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ and Levin B: bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55: 237-241, 1995.
23. Hiyoshi H, Matsuno Y, Kato H, Shimosato Y and Hirohashi S: Clinopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer. Jpn J Cancer Res 83: 101-106, 1992.
24. Martin HM, Filipe MI, Morris RN, Lane DP and Silvester I: p53 expression and prognosis in gastric carcinoma. Int J Cancer 50: 859-862, 1992.
25. Forschen R, Remy U, Bevers G, Schauseil S, Hengels KJ and Borchard F: Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffinembedded specimens. Cancer 71: 3846-3850, 1993.
26. Silvestrini R, D'Agnaro I, Faranda A, Costa A, Zupi G, Cosimelli M, Quagliuolo V, Giannarelli D, Gennari L and Cavaliere R: Flow cytometric analysis of ploidy in colorectal cancer. A multicentric experience. Br J Cancer 67: 1042-1046, 1993.
27. Morita T, Kuwano H, Matsuda H, Moriguchi S and Sugimachi K: Prognostic significance of argyrophilic nucleolar organizer regions in esophageal carcinoma. Cancer Res 51: 5339-5341, 1991.
28. Toyota N, Katano K, Takahashi S, Ohtani S, Mizusawa K, Hamazoe R and Kaibara N: The argyrophilic nucleolar organizer region (Ag-NOR) score in invasive ductal carcinoma of the pancreas. Jpn J Surg 27: 414-419, 1997.